banner add

Officials Cast Doubt on a Dementia Drug, but Human Trials Continue

The S.E.C. alleged shortcomings in research said to support the drug, and its developer agreed to a $40 million settlement. Some experts wonder why clinical trials have not been stopped.

from NYT > Health https://ift.tt/HO1FV4S
via IFTTT

No comments

Telemedicine for Seniors Gets a Last-Minute Reprieve

Some older Americans have come to depend on virtual consultations with doctors, covered by Medicare. To keep that option in the future, Cong...

Theme images by PLAINVIEW. Powered by Blogger.